Related Experiment Videos
Ketoconazole in experimental vaginal candidosis in rats
Antimicrobial Agents and Chemotherapy
|November 1, 1986
Abstract:
Rats in pseudoestrous were treated subcutaneously with ketoconazole at 25 mg/kg twice a day. In both uninfected and infected rats ketoconazole inhibited the cornification of the vaginal epithelium. Thus, ketoconazole, in addition to having an antifungal effect, may aid in the removal of candida by inhibiting the epithelial conditions suitable for hyphal invasion.
Insights
Ketoconazole treatment in rats prevented vaginal epithelial cornification, suggesting it may help clear Candida infections by altering the environment. This antifungal agent shows potential beyond its direct microbial action.
Area of Science:
- Mycology
- Pharmacology
- Gynecological Health
Background:
- Candida species are common causes of vaginal infections.
- Epithelial changes in the vagina can influence susceptibility to Candida.
- Ketoconazole is an established antifungal medication.
Purpose of the Study:
- To investigate the effect of ketoconazole on vaginal epithelial cornification in rats.
- To explore potential mechanisms of Candida clearance by ketoconazole beyond direct antifungal activity.
Main Methods:
- Rats in pseudoestrous were administered ketoconazole subcutaneously at 25 mg/kg twice daily.
- Vaginal epithelial changes were assessed in both uninfected and Candida-infected rats.
Main Results:
- Ketoconazole significantly inhibited vaginal epithelial cornification in all treated rats.
- This effect was observed irrespective of the presence or absence of Candida infection.
Conclusions:
- Ketoconazole possesses properties that inhibit vaginal epithelial cornification.
- By altering the vaginal environment, ketoconazole may enhance Candida removal, complementing its direct antifungal effects.